Atlas Trials

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer

Clinical trial NCT03540199 · WITHDRAWN

Trial details

NCT number
NCT03540199
Sponsor
Fuda Cancer Hospital, Guangzhou
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Kidney Cancer
Start date
2018-04-10
Primary completion
2020-05-20
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.